| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |